A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B167, Alone and in Combination With Tislelizumab in Patients With Selected Advanced or Metastatic Solid Tumors

  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date4/08/22 → 3/08/27

Keywords

  • Phase 1 and 2 study
  • treatment safety
  • treatment efficacy
  • Pharmacodynamics
  • pharmacokinetics
  • solid tumours